Goldman Sachs Group Inc Kiromic Biopharma, Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

May 14, 2024
BUY
$0.26 - $0.87 $2,886 - $9,657
11,100 New
11,100 $5,000
Q2 2022

Aug 15, 2022
BUY
$0.26 - $0.87 $2,886 - $9,657
11,100 New
11,100 $5,000

Others Institutions Holding KRBP

# of Institutions
2
Shares Held
107K
Call Options Held
0
Put Options Held
0
View Full List

About Kiromic Biopharma, Inc.

KRBP Quotes by TradingView
  • Ticker KRBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,843,200
  • Market Cap $15.8M
  • Description
  • Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate tar...
More about KRBP
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email